Published in J Virol on October 01, 1976
5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA. J Virol (1977) 3.38
Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother (1977) 2.71
Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A (1980) 2.56
Segments of influenza virus complementary RNA synthesized in vitro. J Virol (1978) 1.97
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
Reversible RNA adenosine methylation in biological regulation. Trends Genet (2012) 1.93
Localization of the 5' terminus of late SV40 mRNA. Nucleic Acids Res (1978) 1.80
The segments of influenza viral mRNA. J Virol (1977) 1.51
Use of specific radioactive probes to study transcription and replication of the influenza virus genome. J Virol (1977) 1.36
Characterization of the 5'-terminal capped structures of late simian virus 40-specific mRNA. J Virol (1978) 1.36
RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev (2015) 1.29
Influenza A: understanding the viral life cycle. Yale J Biol Med (2009) 1.17
Absence of detectable capping and methylating enzymes in influenza virions. J Virol (1978) 1.14
Unique features of the m6A methylome in Arabidopsis thaliana. Nat Commun (2014) 1.04
Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells. Nat Microbiol (2016) 1.03
The 5' ends of Thogoto virus (Orthomyxoviridae) mRNAs are homogeneous in both length and sequence. J Virol (1996) 1.01
Biogenesis, assembly, and export of viral messenger ribonucleoproteins in the influenza A virus infected cell. RNA Biol (2013) 0.96
Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. Cell Host Microbe (2016) 0.96
Cell-free coupling of influenza virus RNA transcription and translation. J Virol (1977) 0.95
Unequal distribution of N6-methyladenosine in influenza virus mRNAs. Mol Cell Biol (1987) 0.95
Widespread occurrence of N6-methyladenosine in bacterial mRNA. Nucleic Acids Res (2015) 0.95
In vitro polymerase activity of Thogoto virus: evidence for a unique cap-snatching mechanism in a tick-borne orthomyxovirus. J Virol (1997) 0.95
N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. Elife (2016) 0.92
N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection. Cell Host Microbe (2016) 0.87
Recent advances in dynamic m6A RNA modification. Open Biol (2016) 0.86
Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol (2016) 0.86
Dynamics of Human and Viral RNA Methylation during Zika Virus Infection. Cell Host Microbe (2016) 0.84
Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent. Infect Immun (1982) 0.83
S-adenosyl-L-homocysteine as a stimulator of viral RNA synthesis by two distinct cytoplasmic polyhedrosis viruses. J Virol (1978) 0.81
Common sequence at the 5' ends of the segmented RNA genomes of influenza A and B viruses. J Virol (1978) 0.81
Viral Epitranscriptomics. J Virol (2017) 0.78
RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling. MBio (2016) 0.78
Making the Mark: The Role of Adenosine Modifications in the Life Cycle of RNA Viruses. Cell Host Microbe (2017) 0.76
RNA modifications go viral. PLoS Pathog (2017) 0.75
Interactions between the HIV-1 Unspliced mRNA and Host mRNA Decay Machineries. Viruses (2016) 0.75
The emerging biology of RNA post-transcriptional modifications. RNA Biol (2016) 0.75
Viral cell biology: HIV RNA gets methylated. Nat Microbiol (2016) 0.75
Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N(6)-Adenosine Methylation to Promote Lytic Replication. J Virol (2017) 0.75
Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication. Cell Host Microbe (2017) 0.75
Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-. Proc Natl Acad Sci U S A (1975) 6.26
Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA. Proc Natl Acad Sci U S A (1975) 5.16
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
Methylated nucleotides block 5' terminus of HeLa cell messenger RNA. Cell (1975) 3.46
Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem (1975) 3.44
Structure of the poliovirus replicative intermediate RNA. J Mol Biol (1968) 3.31
Methylated, blocked 5 termini in HeLa cell mRNA. Proc Natl Acad Sci U S A (1975) 3.02
The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus. Cell (1975) 2.82
Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells. Proc Natl Acad Sci U S A (1975) 2.81
Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology (1973) 2.40
5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA. Biochemistry (1976) 2.28
Transcription of the influenza ribonucleic acid genome by a virion polymerase. II. Nature of the in vitro polymerase product. J Virol (1971) 2.27
Characterization of the subunit structure of the ribonucleic acid genome of influenza virus. J Virol (1971) 2.22
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Influenza virion RNA-dependent RNA polymerase: stimulation by guanosine and related compounds. J Virol (1975) 2.18
Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts. J Virol (1975) 2.17
Influenza viral messenger RNA. Virology (1974) 1.99
Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5' terminus. Biochemistry (1975) 1.96
Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics. Virology (1970) 1.95
Sequence of methylated nucleotides at the 5'-terminus of adenovirus-specific RNA. J Virol (1976) 1.94
5'-terminus of influenza virus RNA. Nat New Biol (1971) 1.93
A reexamination of influenza single-and double-stranded RNAs by gel electrophoresis. Virology (1976) 1.93
Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells. Virology (1972) 1.92
Characterization of the mRNA of influenza virus. J Virol (1975) 1.71
The inhibition of influenza virus RNA synthesis by actinomycin D and cycloheximide. Virology (1973) 1.65
New virus-specific antigens in cells infected with influenza virus. Virology (1969) 1.48
Isolation of intact individual species of single- and double-stranded RNA after fractionation by polyacrylamide gel electrophoresis. Anal Biochem (1975) 1.47
Studies on the intranuclear localization of influenza virus-specific proteins. Virology (1975) 1.38
The polypeptides of influenza virus. 1. Cytoplasmic synthesis and nuclear accumulation. Virology (1969) 1.12
Replication of bacteriophage RNA: purification of the replicative intermediate by agarose column chromatography-1. Biochem Biophys Res Commun (1966) 1.07
Failure of an influenza virus to initiate infection in enucleate BHK cells. J Virol (1974) 1.00
Characterization of the end groups of RNA of Rous sarcoma virus. Proc Natl Acad Sci U S A (1974) 0.91
Polyadenylate sequences of fowl plague virus complementary RNA (cRNA) synthesized in vivo and in vitro. Virology (1975) 0.90
Hybridization studies of the relationship between influenza virus RNA and cellular DNA. Virology (1976) 0.87
Capping of eucaryotic mRNAs. Cell (1976) 10.84
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol (1983) 7.02
RNA polymerase activity in purified reoviruses. Proc Natl Acad Sci U S A (1968) 6.61
Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-. Proc Natl Acad Sci U S A (1975) 6.26
An extracellular H2O2-requiring enzyme preparation involved in lignin biodegradation by the white rot basidiomycete Phanerochaete chrysosporium. Biochem Biophys Res Commun (1983) 6.04
Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell (1998) 5.60
Separation of ten reovirus genome segments by polyacrylamide gel electrophoresis. J Virol (1968) 5.33
5'-Terminal structure and mRNA stability. Nature (1977) 5.32
Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A (1981) 5.10
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med (1995) 4.79
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J (2001) 4.61
5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature (1975) 4.45
A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA. Proc Natl Acad Sci U S A (1978) 4.45
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 4.43
New initiation factor activity required for globin mRNA translation. J Biol Chem (1983) 4.31
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol (1999) 4.10
mRNA cap binding proteins: essential factors for initiating translation. Cell (1985) 4.07
Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell (1983) 3.93
Three structural polypeptides coded for by minite virus of mice, a parvovirus. J Virol (1976) 3.74
Viral and cellular mRNA capping: past and prospects. Adv Virus Res (2000) 3.67
Nucleic acid from an adeno-associated virus: chemical and physical studies. Proc Natl Acad Sci U S A (1966) 3.55
Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J Virol (1988) 3.49
The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol (1994) 3.48
Methylated messenger RNA synthesis in vitro by purified reovirus. Proc Natl Acad Sci U S A (1974) 3.44
Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells. J Biol Chem (1981) 3.41
Inactivity of purified reovirus RNA as a template for E. coli polymerases in vitro. Proc Natl Acad Sci U S A (1965) 3.40
Sequences containing methylated nucleotides at the 5' termini of messenger RNAs: possible implications for processing. Cell (1974) 3.39
Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA. J Virol (1977) 3.38
Sequence homology between the structural polypeptides of minute virus of mice. J Mol Biol (1977) 3.37
Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J (1999) 3.35
Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell (1979) 3.35
Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc Natl Acad Sci U S A (1997) 3.14
Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A (1979) 3.10
Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end. Proc Natl Acad Sci U S A (1986) 3.09
Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase. J Virol (1970) 3.07
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
Methylated, blocked 5 termini in HeLa cell mRNA. Proc Natl Acad Sci U S A (1975) 3.02
5'-Terminal m-7G(5')ppp(5')G-m-p in vivo: identification in reovirus genome RNA. Proc Natl Acad Sci U S A (1975) 3.01
Reovirus-directed ribonucleic acid synthesis in infected L cells. J Virol (1967) 3.00
Migration of 40 S ribosomal subunits on messenger RNA in the presence of edeine. J Biol Chem (1978) 2.84
Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc Natl Acad Sci U S A (1979) 2.81
Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells. Proc Natl Acad Sci U S A (1975) 2.81
Ribosome binding to reovirus mRNA in protein synthesis requires 5' terminal 7-methylguanosine. Cell (1975) 2.78
Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol (1975) 2.72
Transcription by infectious subviral particles of reovirus. J Virol (1972) 2.70
Predictive factors for neonatal morbidity in neonates with an umbilical arterial cord pH less than 7.00. Am J Obstet Gynecol (1997) 2.68
Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol (1981) 2.68
Blocked, methylated 5'-terminal sequence in avian sarcoma virus RNA. Nature (1975) 2.66
The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev (1994) 2.64
Origin of splice junction phosphate in tRNAs processed by HeLa cell extract. Cell (1983) 2.62
Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence, m7GpppGmpC. J Biol Chem (1976) 2.60
Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A (1980) 2.56
Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol (1994) 2.54
Influenza virus temperature-sensitive cap (m7GpppNm)-dependent endonuclease. J Virol (1983) 2.53
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1980) 2.46
Synthesis of all the gene products of the reovirus genome in vivo and in vitro. Cell (1975) 2.42
Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol (1997) 2.41
Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. Virology (1973) 2.40
Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J Virol (1985) 2.38
Single-stranded, adenine-rich RNA from purified reoviruses. Proc Natl Acad Sci U S A (1968) 2.37
Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J Virol (1987) 2.21
The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J Virol (1987) 2.20
Evaluation of an enzyme-linked immunosorbent assay for the detection of herpes simplex virus antigen. J Clin Microbiol (1984) 2.19
Influenza viral RNPs newly synthesized during the latent period of viral growth in MDCK cells. Virology (1971) 2.19
Purification of influenza viral complementary RNA: its genetic content and activity in wheat germ cell-free extracts. J Virol (1975) 2.17
A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol (1997) 2.16
Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames. Proc Natl Acad Sci U S A (1985) 2.15
The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA (1995) 2.12
Polynucleotide ligase activity in cells infected with simian virus 40, polyoma virus, or vaccinia virus. J Virol (1969) 2.08
The 5'-terminal nucleotide sequences of the double-stranded RNA of human reovirus. Proc Natl Acad Sci U S A (1974) 2.08
Transcription elongation factor hSPT5 stimulates mRNA capping. Genes Dev (1999) 2.06
Palliative fetal surgery for diaphragmatic hernia. Am J Obstet Gynecol (1994) 2.05
Molecular cloning of double-stranded RNA virus genomes. Proc Natl Acad Sci U S A (1983) 2.01
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
Influenza viral messenger RNA. Virology (1974) 1.99
Segments of influenza virus complementary RNA synthesized in vitro. J Virol (1978) 1.97
Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Mol Cell Biol (1984) 1.97
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A (1998) 1.94
Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus. J Clin Microbiol (1986) 1.93
Sequences and properties of two ribosome binding sites from the small size class of reovirus messenger RNA. J Biol Chem (1977) 1.93
Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells. Virology (1972) 1.92
The Healthy Neighborhoods Project: a local health department's role in catalyzing community development. Health Educ Behav (1998) 1.89
Characterization of ribosome-protected fragments from reovirus messenger RNA. J Biol Chem (1976) 1.87
Complete amino acid sequence of the basic nucleic acid binding protein of feline leukemia virus. Virology (1984) 1.86
Identification of features in 5' terminal fragments from reovirus mRNA which are important for ribosome binding. Cell (1978) 1.86
Effect of 5'-terminal structure and base composition on polyribonucleotide binding to ribosomes. J Mol Biol (1976) 1.84